BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goncalves A, Peeling RW, Chu MC, Gubler DJ, de Silva AM, Harris E, Murtagh M, Chua A, Rodriguez W, Kelly C, Wilder-Smith A. Innovative and New Approaches to Laboratory Diagnosis of Zika and Dengue: A Meeting Report. J Infect Dis 2018;217:1060-8. [PMID: 29294035 DOI: 10.1093/infdis/jix678] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Čabanová V, Kerlik J, Kirschner P, Rosochová J, Klempa B, Sláviková M, Ličková M. Co-Circulation of West Nile, Usutu, and Tick-Borne Encephalitis Viruses in the Same Area: A Great Challenge for Diagnostic and Blood and Organ Safety. Viruses 2023;15. [PMID: 36851580 DOI: 10.3390/v15020366] [Reference Citation Analysis]
2 Choi G, Moehling TJ, Meagher RJ. Advances in RT-LAMP for COVID-19 testing and diagnosis. Expert Rev Mol Diagn 2023;23:9-28. [PMID: 36695788 DOI: 10.1080/14737159.2023.2169071] [Reference Citation Analysis]
3 Matthes A, Bleidorn J, Markwart R. Research on point-of-care tests in outpatient care in Germany: A scoping review and definition of relevant endpoints in evaluation studies. Z Evid Fortbild Qual Gesundhwes 2022;174:1-10. [PMID: 36055890 DOI: 10.1016/j.zefq.2022.06.002] [Reference Citation Analysis]
4 Chan KR, Ismail AA, Thergarajan G, Raju CS, Yam HC, Rishya M, Sekaran SD. Serological cross-reactivity among common flaviviruses. Front Cell Infect Microbiol 2022;12:975398. [DOI: 10.3389/fcimb.2022.975398] [Reference Citation Analysis]
5 Haider M, Yousaf S, Zaib A, Sarfraz A, Sarfraz Z, Cherrez-Ojeda I. Diagnostic Accuracy of Various Immunochromatographic Tests for NS1 Antigen and IgM Antibodies Detection in Acute Dengue Virus Infection. Int J Environ Res Public Health 2022;19. [PMID: 35886607 DOI: 10.3390/ijerph19148756] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wong JM, Adams LE, Durbin AP, Muñoz-Jordán JL, Poehling KA, Sánchez-González LM, Volkman HR, Paz-Bailey G. Dengue: A Growing Problem With New Interventions. Pediatrics 2022;149:e2021055522. [PMID: 35543085 DOI: 10.1542/peds.2021-055522] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
7 Lai S, Huang Y, Wey J, Tsai M, Chen Y, Shu P, Chang S, Hung Y, Hou J, Lin C. Development of Novel Dengue NS1 Multiplex Lateral Flow Immunoassay to Differentiate Serotypes in Serum of Acute Phase Patients and Infected Mosquitoes. Front Immunol 2022;13:852452. [DOI: 10.3389/fimmu.2022.852452] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Kelly AH, Lezaun J, Street A. Global health, accelerated: Rapid diagnostics and the fragile solidarities of ‘emergency R&D’. Economy and Society. [DOI: 10.1080/03085147.2021.2014730] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Wilder-Smith A, Brickley EB, Ximenes RAA, Miranda-Filho DB, Turchi Martelli CM, Solomon T, Jacobs BC, Pardo CA, Osorio L, Parra B, Lant S, Willison HJ, Leonhard S, Turtle L, Ferreira MLB, de Oliveira Franca RF, Lambrechts L, Neyts J, Kaptein S, Peeling R, Boeras D, Logan J, Dolk H, Orioli IM, Neumayr A, Lang T, Baker B, Massad E, Preet R. The legacy of ZikaPLAN: a transnational research consortium addressing Zika. Glob Health Action 2021;14:2008139. [PMID: 35377284 DOI: 10.1080/16549716.2021.2008139] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Mota ML, Dos Santos Souza Marinho R, Duro RLS, Hunter J, de Menezes IRA, de Lima Silva JMF, Pereira GLT, Sabino EC, Grumach A, Diaz RS, do Socorro Lucena M, Komninakis SV. Serological and molecular epidemiology of the Dengue, Zika and Chikungunya viruses in a risk area in Brazil. BMC Infect Dis 2021;21:704. [PMID: 34303348 DOI: 10.1186/s12879-021-06401-3] [Reference Citation Analysis]
11 Castillo-León J, Trebbien R, Castillo JJ, Svendsen WE. Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges. Analyst 2021;146:3750-76. [PMID: 34060546 DOI: 10.1039/d0an02286a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
12 Jacques IJAA, Katz L, Sena MA, Guimarães ABG, Silva YL, Albuquerque GDM, Pereira RO, de Albuquerque CAMC, Silva MAL, Oliveira PAS, Albuquerque MFPM, Cordeiro MT, Marques ETA Jr, França RFO, Martelli CMT, Castanha PMS, Braga C. High Incidence of Zika or Chikungunya Infection among Pregnant Women Hospitalized Due to Obstetrical Complications in Northeastern Brazil-Implications for Laboratory Screening in Arbovirus Endemic Area. Viruses 2021;13:744. [PMID: 33922819 DOI: 10.3390/v13050744] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Leon F, Pinchon E, Temurok N, Morvan F, Vasseur JJ, Clot M, Foulongne V, Cantaloube JF, Vande Perre P, Molès JP, Daynès A, Fournier-Wirth C. Diagnostic Performance of a Magnetic Field-Enhanced Agglutination Readout in Detecting Either Viral Genomes or Host Antibodies in Arbovirus Infection. Microorganisms 2021;9:674. [PMID: 33805173 DOI: 10.3390/microorganisms9040674] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Allgoewer K, Maity S, Zhao A, Lashua L, Ramgopal M, Balkaran BN, Liu L, Purushwani S, Arévalo MT, Ross TM, Choi H, Ghedin E, Vogel C. New Proteomic Signatures to Distinguish Between Zika and Dengue Infections. Mol Cell Proteomics 2021;20:100052. [PMID: 33582300 DOI: 10.1016/j.mcpro.2021.100052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
15 Kweon OJ, Lim YK, Kim HR, Kim MC, Choi SH, Chung JW, Lee MK. Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays. PLoS One 2020;15:e0240395. [PMID: 33091042 DOI: 10.1371/journal.pone.0240395] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
16 Wiwanitkit V. Challenges in the diagnosis of dengue. Future Virology 2020;15:485-7. [DOI: 10.2217/fvl-2020-0058] [Reference Citation Analysis]
17 Wilder-Smith A. The first licensed dengue vaccine: can it be used in travelers? Curr Opin Infect Dis 2019;32:394-400. [PMID: 31305495 DOI: 10.1097/QCO.0000000000000573] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
18 Angelo KM, Stoney RJ, Brun-Cottan G, Leder K, Grobusch MP, Hochberg N, Kuhn S, Bottieau E, Schlagenhauf P, Chen L, Hynes NA, Perez CP, Mockenhaupt FP, Molina I, Crespillo-Andújar C, Malvy D, Caumes E, Plourde P, Shaw M, McCarthy AE, Piper-Jenks N, Connor BA, Hamer DH, Wilder-Smith A. Zika among international travellers presenting to GeoSentinel sites, 2012-2019: implications for clinical practice. J Travel Med 2020;27. [PMID: 32330261 DOI: 10.1093/jtm/taaa061] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
19 Halstead SB, Katzelnick LC, Russell PK, Markoff L, Aguiar M, Dans LR, Dans AL. Ethics of a partially effective dengue vaccine: Lessons from the Philippines. Vaccine 2020;38:5572-6. [PMID: 32654899 DOI: 10.1016/j.vaccine.2020.06.079] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 9.7] [Reference Citation Analysis]
20 Wilder-Smith A, Preet R, Brickley EB, Ximenes RAA, Miranda-Filho DB, Turchi Martelli CM, Araújo TVB, Montarroyos UR, Moreira ME, Turchi MD, Solomon T, Jacobs BC, Villamizar CP, Osorio L, de Filipps AMB, Neyts J, Kaptein S, Huits R, Ariën KK, Willison HJ, Edgar JM, Barnett SC, Peeling R, Boeras D, Guzman MG, de Silva AM, Falconar AK, Romero-Vivas C, Gaunt MW, Sette A, Weiskopf D, Lambrechts L, Dolk H, Morris JK, Orioli IM, O'Reilly KM, Yakob L, Rocklöv J, Soares C, Ferreira MLB, Franca RFO, Precioso AR, Logan J, Lang T, Jamieson N, Massad E. ZikaPLAN: addressing the knowledge gaps and working towards a research preparedness network in the Americas. Glob Health Action 2019;12:1666566. [PMID: 31640505 DOI: 10.1080/16549716.2019.1666566] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
21 Hurtado-Monzón AM, Cordero-Rivera CD, Farfan-Morales CN, Osuna-Ramos JF, De Jesús-González LA, Reyes-Ruiz JM, Del Ángel RM. The role of anti-flavivirus humoral immune response in protection and pathogenesis. Rev Med Virol 2020;30:e2100. [PMID: 32101633 DOI: 10.1002/rmv.2100] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
22 Kim HO, Na W, Yeom M, Lim JW, Bae EH, Park G, Park C, Lee H, Kim HK, Jeong DG, Lyoo KS, Le VP, Haam S, Song D. Dengue Virus-Polymersome Hybrid Nanovesicles for Advanced Drug Screening Using Real-Time Single Nanoparticle-Virus Tracking. ACS Appl Mater Interfaces 2020;12:6876-84. [PMID: 31950828 DOI: 10.1021/acsami.9b20492] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
23 Quanquin N, Adachi K, Nielsen-saines K. Zika virus. Maternal Immunization 2020. [DOI: 10.1016/b978-0-12-814582-1.00014-0] [Reference Citation Analysis]
24 Kerkhof K, Falconi-Agapito F, Van Esbroeck M, Talledo M, Ariën KK. Reliable Serological Diagnostic Tests for Arboviruses: Feasible or Utopia? Trends Microbiol 2020;28:276-92. [PMID: 31864844 DOI: 10.1016/j.tim.2019.11.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
25 Wilder-smith A. Yellow Fever in Travelers. Curr Infect Dis Rep 2019;21. [DOI: 10.1007/s11908-019-0701-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
26 Mascini M, Dikici E, Robles Mañueco M, Perez-Erviti JA, Deo SK, Compagnone D, Wang J, Pingarrón JM, Daunert S. Computationally Designed Peptides for Zika Virus Detection: An Incremental Construction Approach. Biomolecules 2019;9:E498. [PMID: 31533374 DOI: 10.3390/biom9090498] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
27 Wilder-Smith A, Smith PG, Luo R, Kelly-Cirino C, Curry D, Larson H, Durbin A, Chu M, Tharmaphornpilas P, Ng LC, Sartori AMC, Luna EJA, Gubler DJ, España G, Yoon IK, Flasche S. Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report. Vaccine 2019;37:5137-46. [PMID: 31377079 DOI: 10.1016/j.vaccine.2019.07.016] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
28 Amrun SN, Yee WX, Abu Bakar F, Lee B, Kam YW, Lum FM, Tan JJ, Lim VW, Watthanaworawit W, Ling C, Nosten F, Renia L, Leo YS, Ng LF. Novel differential linear B-cell epitopes to identify Zika and dengue virus infections in patients. Clin Transl Immunology 2019;8:e1066. [PMID: 31372218 DOI: 10.1002/cti2.1066] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
29 Tello-Cajiao ME, Osorio L. Impact of Dengue Rapid Diagnostic Tests on the Prescription of Antibiotics and Anti-Inflammatory Drugs by Physicians in an Endemic Area in Colombia. Am J Trop Med Hyg 2019;101:696-704. [PMID: 31333163 DOI: 10.4269/ajtmh.19-0222] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 España G, Yao Y, Anderson KB, Fitzpatrick MC, Smith DL, Morrison AC, Wilder-Smith A, Scott TW, Perkins TA. Model-based assessment of public health impact and cost-effectiveness of dengue vaccination following screening for prior exposure. PLoS Negl Trop Dis 2019;13:e0007482. [PMID: 31260441 DOI: 10.1371/journal.pntd.0007482] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
31 Wilder-Smith A, Wei Y, Araújo TVB, VanKerkhove M, Turchi Martelli CM, Turchi MD, Teixeira M, Tami A, Souza J, Sousa P, Soriano-Arandes A, Soria-Segarra C, Sanchez Clemente N, Rosenberger KD, Reveiz L, Prata-Barbosa A, Pomar L, Pelá Rosado LE, Perez F, Passos SD, Nogueira M, Noel TP, Moura da Silva A, Moreira ME, Morales I, Miranda Montoya MC, Miranda-Filho DB, Maxwell L, Macpherson CNL, Low N, Lan Z, LaBeaud AD, Koopmans M, Kim C, João E, Jaenisch T, Hofer CB, Gustafson P, Gérardin P, Ganz JS, Dias ACF, Elias V, Duarte G, Debray TPA, Cafferata ML, Buekens P, Broutet N, Brickley EB, Brasil P, Brant F, Bethencourt S, Benedetti A, Avelino-Silva VL, Ximenes RAA, Alves da Cunha A, Alger J; Zika Virus Individual Participant Data Consortium. Understanding the relation between Zika virus infection during pregnancy and adverse fetal, infant and child outcomes: a protocol for a systematic review and individual participant data meta-analysis of longitudinal studies of pregnant women and their infants and children. BMJ Open 2019;9:e026092. [PMID: 31217315 DOI: 10.1136/bmjopen-2018-026092] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
32 Amrun SN, Yee W, Bakar FA, Lee B, Kam Y, Lum F, Tan JJ, Lim VW, Watthanaworawit W, Ling C, Nosten F, Renia L, Leo Y, Ng LF. Novel differential linear B-cell epitopes to identify Zika and dengue virus infections in patients.. [DOI: 10.1101/639542] [Reference Citation Analysis]
33 Wilder-Smith A, Tissera H, AbuBakar S, Kittayapong P, Logan J, Neumayr A, Rocklöv J, Byass P, Louis VR, Tozan Y, Massad E, Preet R. Novel tools for the surveillance and control of dengue: findings by the DengueTools research consortium. Glob Health Action 2018;11:1549930. [PMID: 30560735 DOI: 10.1080/16549716.2018.1549930] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
34 Castanha PMS, Souza WV, Braga C, Araújo TVB, Ximenes RAA, Albuquerque MFPM, Montarroyos UR, Miranda-Filho DB, Cordeiro MT, Dhalia R, Marques ETA Jr, Rodrigues LC, Martelli CMT; Microcephaly Epidemic Research Group. Perinatal analyses of Zika- and dengue virus-specific neutralizing antibodies: A microcephaly case-control study in an area of high dengue endemicity in Brazil. PLoS Negl Trop Dis 2019;13:e0007246. [PMID: 30856223 DOI: 10.1371/journal.pntd.0007246] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 6.5] [Reference Citation Analysis]
35 Van den Bossche D, Michiels J, Cnops L, Foque N, Meersman K, Huits R, Ariën KK, Van Esbroeck M. Challenges in diagnosing Zika-experiences from a reference laboratory in a non-endemic setting. Eur J Clin Microbiol Infect Dis 2019;38:771-8. [PMID: 30680570 DOI: 10.1007/s10096-019-03472-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
36 Luo R, Fongwen N, Kelly-Cirino C, Harris E, Wilder-Smith A, Peeling RW. Rapid diagnostic tests for determining dengue serostatus: a systematic review and key informant interviews. Clin Microbiol Infect 2019;25:659-66. [PMID: 30664935 DOI: 10.1016/j.cmi.2019.01.002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 9.3] [Reference Citation Analysis]
37 Vannice KS, Cassetti MC, Eisinger RW, Hombach J, Knezevic I, Marston HD, Wilder-Smith A, Cavaleri M, Krause PR. Demonstrating vaccine effectiveness during a waning epidemic: A WHO/NIH meeting report on approaches to development and licensure of Zika vaccine candidates. Vaccine 2019;37:863-8. [PMID: 30639461 DOI: 10.1016/j.vaccine.2018.12.040] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 11.3] [Reference Citation Analysis]
38 Lim SP. Dengue drug discovery: Progress, challenges and outlook. Antiviral Res 2019;163:156-78. [PMID: 30597183 DOI: 10.1016/j.antiviral.2018.12.016] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 9.4] [Reference Citation Analysis]
39 Land KJ, Boeras DI, Chen XS, Ramsay AR, Peeling RW. REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes. Nat Microbiol 2019;4:46-54. [PMID: 30546093 DOI: 10.1038/s41564-018-0295-3] [Cited by in Crossref: 195] [Cited by in F6Publishing: 206] [Article Influence: 39.0] [Reference Citation Analysis]
40 Peeling RW, Murtagh M, Olliaro PL. Epidemic preparedness: why is there a need to accelerate the development of diagnostics? Lancet Infect Dis 2019;19:e172-8. [PMID: 30551872 DOI: 10.1016/S1473-3099(18)30594-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
41 Heffron AS, Mohr EL, Baker D, Haj AK, Buechler CR, Bailey A, Dudley DM, Newman CM, Mohns MS, Koenig M, Breitbach ME, Rasheed M, Stewart LM, Eickhoff J, Pinapati RS, Beckman E, Li H, Patel J, Tan JC, O'Connor DH. Antibody responses to Zika virus proteins in pregnant and non-pregnant macaques. PLoS Negl Trop Dis 2018;12:e0006903. [PMID: 30481182 DOI: 10.1371/journal.pntd.0006903] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
42 Britto C, Dold C, Reyes-Sandoval A, Rollier CS. Rapid travel to a Zika vaccine: are we heading towards success or more questions? Expert Opin Biol Ther 2018;18:1171-9. [PMID: 30235422 DOI: 10.1080/14712598.2018.1526277] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
43 Ariën KK, Wilder-smith A. Dengue vaccine: reliably determining previous exposure. The Lancet Global Health 2018;6:e830-1. [DOI: 10.1016/s2214-109x(18)30295-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
44 España G, Yao Y, Anderson KB, Fitzpatrick MC, Smith DL, Morrison AC, Wilder-smith A, Scott TW, Perkins TA. Model-based assessment of public health impact and cost-effectiveness of dengue vaccination following screening for prior exposure.. [DOI: 10.1101/367060] [Reference Citation Analysis]
45 Heffron AS, Mohr EL, Baker D, Haj AK, Buechler CR, Bailey A, Dudley DM, Newman CM, Mohns MS, Koenig M, Breitbach ME, Rasheed M, Stewart LM, Eickhoff J, Pinapati RS, Beckman E, Li H, Patel J, Tan JC, O’connor DH. Antibody responses to Zika virus proteins in pregnant and non-pregnant macaques.. [DOI: 10.1101/352880] [Reference Citation Analysis]
46 Kim DTH, Bao DT, Park H, Ngoc NM, Yeo SJ. Development of a novel peptide aptamer-based immunoassay to detect Zika virus in serum and urine. Theranostics 2018;8:3629-42. [PMID: 30026871 DOI: 10.7150/thno.25955] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
47 Wilder-Smith A, Vannice K, Durbin A, Hombach J, Thomas SJ, Thevarjan I, Simmons CP. Zika vaccines and therapeutics: landscape analysis and challenges ahead. BMC Med 2018;16:84. [PMID: 29871628 DOI: 10.1186/s12916-018-1067-x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 12.6] [Reference Citation Analysis]
48 Semenova T, Voigt A, Donelan W, Aranyos A, Yamamoto J, Rathore MR, Nguyen CQ. Development of an on-chip detection of Zika virus and antibodies simultaneously using array of nanowells.. [DOI: 10.1101/302893] [Reference Citation Analysis]